Kakeru Hisakane
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 21, 2024
Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion.Kakeru Hisakane, Kenichiro Atsumi, Masahiro Seike
|Sep 05, 2024
Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series.Kaoruko Shimbu, Kakeru Hisakane, Naohiro Kadoma
|Jun 08, 2023
Platinum-combination chemotherapy with or without immune-checkpoint inhibitor in patients with postoperative recurrent non-small cell lung cancer previously treated with adjuvant platinum-doublet chemotherapy: A multicenter retrospective study.Kakeru Hisakane, Takehiro Tozuka, Satoshi Takahashi
|Sep 10, 2022
Black pleural effusion caused by a pancreaticopleural fistula associated with autoimmune pancreatitis: A case report.Keiki Miyadera, Kakeru Hisakane, Yuki Kato
|May 03, 2021
Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.Kakeru Hisakane, Masahiro Seike, Teppei Sugano
Pageof 1
